PortfoliosLab logo
AMN vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMN and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

AMN vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AMN Healthcare Services, Inc. (AMN) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

AMN:

-1.07

ABBV:

0.71

Sortino Ratio

AMN:

-1.71

ABBV:

0.97

Omega Ratio

AMN:

0.78

ABBV:

1.15

Calmar Ratio

AMN:

-0.74

ABBV:

0.85

Martin Ratio

AMN:

-1.30

ABBV:

2.09

Ulcer Index

AMN:

48.90%

ABBV:

8.49%

Daily Std Dev

AMN:

59.84%

ABBV:

27.46%

Max Drawdown

AMN:

-89.99%

ABBV:

-45.09%

Current Drawdown

AMN:

-82.68%

ABBV:

-14.01%

Fundamentals

Market Cap

AMN:

$840.42M

ABBV:

$328.29B

EPS

AMN:

-$4.33

ABBV:

$2.34

PEG Ratio

AMN:

1.71

ABBV:

0.39

PS Ratio

AMN:

0.28

ABBV:

5.72

PB Ratio

AMN:

1.18

ABBV:

229.63

Total Revenue (TTM)

AMN:

$2.16B

ABBV:

$57.37B

Gross Profit (TTM)

AMN:

$618.77M

ABBV:

$44.44B

EBITDA (TTM)

AMN:

-$56.41M

ABBV:

$16.33B

Returns By Period

In the year-to-date period, AMN achieves a -8.03% return, which is significantly lower than ABBV's 5.83% return. Over the past 10 years, AMN has underperformed ABBV with an annualized return of -1.40%, while ABBV has yielded a comparatively higher 15.72% annualized return.


AMN

YTD

-8.03%

1M

14.35%

6M

-24.27%

1Y

-59.79%

5Y*

-13.57%

10Y*

-1.40%

ABBV

YTD

5.83%

1M

6.95%

6M

-5.73%

1Y

19.02%

5Y*

20.92%

10Y*

15.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMN vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMN
The Risk-Adjusted Performance Rank of AMN is 77
Overall Rank
The Sharpe Ratio Rank of AMN is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of AMN is 44
Sortino Ratio Rank
The Omega Ratio Rank of AMN is 55
Omega Ratio Rank
The Calmar Ratio Rank of AMN is 88
Calmar Ratio Rank
The Martin Ratio Rank of AMN is 1414
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 7373
Overall Rank
The Sharpe Ratio Rank of ABBV is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 6565
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 6868
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8181
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AMN vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AMN Healthcare Services, Inc. (AMN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current AMN Sharpe Ratio is -1.07, which is lower than the ABBV Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of AMN and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

AMN vs. ABBV - Dividend Comparison

AMN has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.46%.


TTM20242023202220212020201920182017201620152014
AMN
AMN Healthcare Services, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ABBV
AbbVie Inc.
3.46%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

AMN vs. ABBV - Drawdown Comparison

The maximum AMN drawdown since its inception was -89.99%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for AMN and ABBV. For additional features, visit the drawdowns tool.


Loading data...

Volatility

AMN vs. ABBV - Volatility Comparison

AMN Healthcare Services, Inc. (AMN) has a higher volatility of 17.36% compared to AbbVie Inc. (ABBV) at 9.90%. This indicates that AMN's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

AMN vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between AMN Healthcare Services, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
734.71M
13.34B
(AMN) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

AMN vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between AMN Healthcare Services, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
29.8%
83.9%
(AMN) Gross Margin
(ABBV) Gross Margin
AMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AMN Healthcare Services, Inc. reported a gross profit of 218.99M and revenue of 734.71M. Therefore, the gross margin over that period was 29.8%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.

AMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AMN Healthcare Services, Inc. reported an operating income of -202.55M and revenue of 734.71M, resulting in an operating margin of -27.6%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.

AMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AMN Healthcare Services, Inc. reported a net income of -187.53M and revenue of 734.71M, resulting in a net margin of -25.5%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.